Quality of Life From Canadian Cancer Trials Group MA.17R: A Randomized Trial of Extending Adjuvant Letrozole to 10 Years.

about

Quality of Life From Canadian Cancer Trials Group MA.17R: A Randomized Trial of Extending Adjuvant Letrozole to 10 Years.

Item

http://www.wikidata.org/entity/Q47556532

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Quality of Life From Canadian ...... djuvant Letrozole to 10 Years.

@en

Quality of Life From Canadian ...... djuvant Letrozole to 10 Years.

@nl

type

Item

label

Quality of Life From Canadian ...... djuvant Letrozole to 10 Years.

@en

Quality of Life From Canadian ...... djuvant Letrozole to 10 Years.

@nl

prefLabel

Quality of Life From Canadian ...... djuvant Letrozole to 10 Years.

@en

Quality of Life From Canadian ...... djuvant Letrozole to 10 Years.

@nl

P1476

Quality of Life From Canadian ...... djuvant Letrozole to 10 Years.

@en

P2093

Dongsheng Tu

http://www.w3.org/2001/XMLSchema#string

Hyman Muss

http://www.w3.org/2001/XMLSchema#string

James N Ingle

http://www.w3.org/2001/XMLSchema#string

Julie Gralow

http://www.w3.org/2001/XMLSchema#string

Julie Lemieux

http://www.w3.org/2001/XMLSchema#string

Kate Whelan

http://www.w3.org/2001/XMLSchema#string

Kathleen I Pritchard

http://www.w3.org/2001/XMLSchema#string

Michael D Brundage

http://www.w3.org/2001/XMLSchema#string

Paul Celano

http://www.w3.org/2001/XMLSchema#string

Paul E Goss

http://www.w3.org/2001/XMLSchema#string

P2860

Analysis and interpretation of health-related quality-of-life data from clinical trials: basic approach of The National Cancer Institute of Canada Clinical Trials Group.

Canadian normative data for the SF-36 health survey. Canadian Multicentre Osteoporosis Study Research Group.

Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years.

Quality of life in MAP.3 (Mammary Prevention 3): a randomized, placebo-controlled trial evaluating exemestane for prevention of breast cancer

Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update on Ovarian Suppression.

Assessment of quality of life in MA.17: a randomized, placebo-controlled trial of letrozole after 5 years of tamoxifen in postmenopausal women.

Benefit from exemestane as extended adjuvant therapy after 5 years of adjuvant tamoxifen: intention-to-treat analysis of the National Surgical Adjuvant Breast And Bowel Project B-33 trial.

The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs.

The natural progression of health-related quality of life: results of a five-year prospective study of SF-36 scores in a normative population.

A menopause-specific quality of life questionnaire: development and psychometric properties.

P304

563-571

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2017.75.7500

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Kathrin Strasser-Weippl

P577

2018-01-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29328860

http://www.w3.org/2001/XMLSchema#string

P932

5815404

http://www.w3.org/2001/XMLSchema#string